Dz13, a c-jun DNAzyme, is a potent inducer of caspase-2 activation

Oligonucleotides

Volumn 20, Issue 3, 2010, Pages 137-146

  Dass, Crispin R ^a   Galloway, Stuart J ^a   Choong, Peter F M ^a,b,c  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 2; DEOXYRIBOZYME; DNA DEPENDENT PROTEIN KINASE; DZ 13; MESSENGER RNA; OLIGONUCLEOTIDE; PROTEIN C JUN; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; DZ13 DNAZYME; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL DEATH; ENZYME ACTIVATION; FEMALE; FIBROBLAST; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOSARCOMA; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; TUMOR CELL LINE; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; ENZYME ACTIVE SITE; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; METABOLISM; NEOPLASM; NICK END LABELING; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

ANIMALS; BASE SEQUENCE; CASPASE 2; CATALYTIC DOMAIN; CELL LINE, TUMOR; DNA PRIMERS; DNA, CATALYTIC; ENZYME ACTIVATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77954114117     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2009.0226     Document Type: Article

References (31)

1. ACS. (2009). Cancer facts and figures 2009. American Cancer Society, Inc., Oklahoma City, OK.
2. ANDERSEN, J.L., JOHNSON, C.E., FREEL, C.D., PARRISH, A.B., DAY, J.L., BUCHAKJIAN, M.R., NUTT, L.K., THOMPSON, J.W., MOSELEY, M.A., and KORNBLUTH, S. (2009). Restraint of apoptosis during mitosis through interdomain phosphor-ylation of caspase-2. EMBO J. 28, 3216-3227.
3. BERGERON, L., PEREZ, G.I., MACDONALD, G., SHI, L., SUN, Y., JURISICOVA, A., VARMUZA, S., LATHAM, K.E., FLAWS, J.A., SALTER, J.C., HARA, H., MOSKOWITZ, M.A., LI, E., GREENBERG, A., TILLY, J.L., and YUAN, J. (1998). Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 12, 1304-1314.
4. CLARK, J.C., DASS, C.R., and CHOONG, P.F. (2008). A review of clinical and molecular prognostic factors in osteosarcoma. J. Cancer Res. Clin. Oncol. 134, 281-297.
5. DASS, C.R., and CHOONG, P.F. (2007). Zoledronic acid inhibits osteosarcoma growth in an orthotopic model. Mol. Cancer Ther. 6, 3263-3270.
6. DASS, C.R., EK, E.T., CONTRERAS, K.G., and CHOONG, P.F. (2006). An orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. Clin. Exp. Metastasis 23, 367-380.
7. DASS, C.R., FRIEDHUBER, A.M., KHACHIGIAN, L.M., DUN-STAN, D.E., and CHOONG, P.F. (2008a). Downregulation of c-jun results in apoptosis-mediated anti-osteosarcoma activity in an orthotopic model. Cancer Biol. Ther. 7, 1033-1036.
8. DASS, C.R., GALLOWAY, S.J., CLARK, J.C., KHACHIGIAN, L.M., and CHOONG, P.F. (2008b). Involvement of c-jun in human liposarcoma growth, supporting data from clinical immunohistochemistry and DNAzyme efficacy. Cancer Biol. Ther. 7, 1297-1301.
9. DASS, C.R, KHACHIGIAN, L.M., and CHOONG, P.F.M. (2008c). c-Jun knockdown sensitizes osteosarcoma to doxo-rubicin. Mol. Cancer Res. 7, 1909-1912.
10. DASS, C.R., SARAVOLAC, E.G., LI, Y., and SUN, L.Q. (2002). Cellular uptake, distribution and stability of 10-23 deoxy-ribozymes. Antisense Nucleic Acid Drug Dev. 12, 289-299.
11. EVAN, G.I., and VOUSDEN, K.H. (2001). Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342-348.
12. GOZAR, M.M., GOODCHILD, A., PASSIOURA, T., KING, A., LAI, A., WITHERINGTON, C., and RIVORY, L. (2008). Dz13, a DNAzyme targeting c-jun, induces off-target cytotoxicity in endothelial cells with features of nonapoptotic programmed cell death. Oligonucleotides 18, 257-268.
13. HO, L.H., READ, S.H., DORSTYN, L., LAMBRUSCO, L., and KUMAR, S. (2008). Caspase-2 is required for cell death induced by cytoskeletal disruption. Oncogene 27, 3393-3404.
14. HO, L.H., TAYLOR, R., DORSTYN, L., CAKOUROS, D., BOUILLET, P., and KUMAR, S. (2009). A tumor suppressor function for caspase-2. Proc. Natl. Acad. Sci. USA 106, 5336-5341.
15. KITEVSKA, T., SPENCER, D.M., and HAWKINS, C.J. (2009). Caspase-2, controversial killer or checkpoint controller? Apoptosis 14, 829-848.
16. KUMAR, S., KINOSHITA, M., NODA, M., COPELAND, N.G., and JENKINS, N.A. (1994). Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. Genes Dev. 8, 1613-1626.
17. LASSUS, P., OPITZ-ARAYA, X., and LAZEBNIK, Y. (2002). Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297, 1352-1354.
18. MANZL, C., KRUMSCHNABEL, G., BOCK, F., SOHM, B., LABI, V., BAUMGARTNER, F., LOGETTE, E., TSCHOPP, J., and VILLUNGER, A. (2009). Caspase-2 activation in the absence of PIDDosome formation. J. Cell Biol. 185, 291-303.
19. MOGI, M., and TOGARI, A. (2003). Activation of caspases is required for osteoblastic differentiation. J. Biol. Chem. 278, 47477-47482.
20. OLSSON, M., VAKIFAHMETOGLU, H., ABRUZZO, P.M., ḦOGSTRAND, K., GRANDIEN, A., and ZHIVOTOVSKY, B. (2009). DISC-mediated activation of caspase-2 in DNA damage-induced apoptosis. Oncogene 28, 1949-1959.
21. ROBERTSON, J.D., ENOKSSON, M., SUOMELA, M., ZHIVO-TOVSKY, B., and ORRENIUS, S. (2002). Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J. Biol. Chem. 277, 29803-29809.
22. SHI, M., VIVIAN, C.J., LEE, K.J., GE, C., MOROTOMI-YANO, K., MANZL, C., BOCK, F., SATO, S., TOMOMORI-SATO, C., ZHU, R., HAUG, J.S., SWANSON, S.K., WASHBURN, M.P., CHEN, D.J., CHEN, B.P., VILLUNGER, A., FLORENS, L., and DU, C. (2009). DNA-PKcs-PIDDosome, a nuclear cas-pase-2-activating complex with role in G2=M checkpoint maintenance. Cell 136, 508-520.
23. TA, H.T., DASS, C.R., CHOONG, P.F., and DUNSTAN, D.E. (2009). Osteosarcoma treatment: state of the art. Cancer Metastasis Rev. 28, 247-263.
24. TAN, M.L., CHOONG, P.F.M., and Dass, C.R. (2009). DNAzyme delivery: getting past first base. Expert Opin. Drug Deliv. 6, 127-138.
25. TIDD, D.M., BROUGHTON, C.M., and CLARK, R.E. (2003). CpG oligodeoxynucleotide 5mer-induced apoptosis in MOLT-4 leukaemia cells does not require caspase 3 or new protein synthesis. Nucleic Acids Res. 31, 2297-2304.
26. TINARI, A., GIAMMARIOLI, A.M., MANGANELLI, V., CIARLO, L., and MALORNI, W. (2008). Analyzing morphological and ultrastructural features in cell death. Methods Enzymol. 442, 1-26.
27. TINEL, A., JANSSENS, S., LIPPENS, S., CUENIN, S., LOGETTE, E., JACCARD, B., QUADRONI, M., and TSCHOPP, J. (2007). Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2 and pro-survival NF-kappaB pathway. EMBO J. 26, 197-208.
28. TINEL, A., and TSCHOPP, J. (2004). The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304, 843-846.
29. VAKIFAHMETOGLU, H., OLSSON, M., ORRENIUS, S., and ZHIVOTOVSKY, B. (2006). Functional connection between p53 and caspase-2 is essential for apoptosis induced by DNA damage. Oncogene 25, 5683-5692.
30. ZHANG, G., DASS, C.R., SUMITHRAN, E., DI GIROLAMO, N., SUN, L.Q., and KHACHIGIAN, L.M. (2004). Effect of deox-yribozymes targeting c-Jun on solid tumor growth and an-giogenesis in rodents. J. Natl. Cancer Inst. 96, 683-696.
31. ZHANG, G., LUO, X., SUMITHRAN, E., PUA, V.S., BARNET-SON, R.S., HALLIDAY, G.M., and KHACHIGIAN, L.M. (2006). Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metallo-proteinase-2 and-9 expression. Oncogene 25, 7260-7266.